Search results for "OSTEOPOROSIS"

showing 10 items of 393 documents

Polymyalgia rheumatica and vertebral fractures: a 1-year pilot controlled study

2010

No data exist about the possibility that vertebral fracture in PMR patients could be independent of steroid therapy. For this reason, we aimed to investigate this topic by a case cohort study with a 1-year follow-up for each patient. We selected ten consecutive patients who experienced vertebral fractures (VF-group) during the first month of 1-year follow-up period and without any other significant associated condition. As a control group we studied ten control patients, without vertebral fractures and with a follow-up of 1 year, randomly selected among a larger group of patients affected by polymyalgia rheumatica. The following data were analysed: eritrosedimention rate (ESR), visual analo…

Malemedicine.medical_specialtyTime FactorsSettore MED/09 - Medicina Internamedicine.drug_classGiant Cell ArteritisImmunologyOsteoporosisPilot Projectslaw.inventionCohort StudiesPolymyalgia rheumaticaRheumatologyRandomized controlled triallawInternal medicinemedicineHumansImmunology and AllergyAgedPain Measurementbusiness.industryCase-control studymedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheRheumatologySurgerySettore MED/16 - ReumatologiaGiant cell arteritisTreatment OutcomePolymyalgia RheumaticaCase-Control StudiesPolymyalgia rheumatica Vertebral fractures Osteoporosis Controlled clinical trialSpinal FracturesCorticosteroidFemalebusinessFollow-Up StudiesCohort studyRheumatology International
researchProduct

Low bone mineral density is a significant risk factor for low-energy distal radius fractures in middle-aged and elderly men: A case-control study

2011

Abstract Background In general there is a lack of data on osteoporosis and fracture in men; this also includes low-energy distal radius fractures. The objectives of this study were to examine BMD and identify factors associated with distal radius fractures in male patients compared with controls recruited from the background population. Methods In a 2-year period, 44 men 50 years or older were diagnosed with low-energy distal radius fractures, all recruited from one hospital. The 31 men who attended for osteoporosis assessment were age-matched with 35 controls. Demographic and clinical data were collected and BMD at femoral neck, total hip and spine L2-4 was assessed by dual energy X-ray ab…

Malemedicine.medical_specialtylcsh:Diseases of the musculoskeletal systemBone density:Medical disciplines: 700::Clinical medical disciplines: 750 [VDP]OsteoporosisPopulationeducationComorbidityAbsorptiometry PhotonRheumatologyBone DensityRisk FactorsInternal medicineHumansMedicineOrthopedics and Sports MedicineProspective StudiesRisk factorProspective cohort studyeducationAgedFemoral neckBone mineraleducation.field_of_studybusiness.industryVDP::Medical disciplines: 700::Health sciences: 800::Preventive medicine: 804Middle Agedmedicine.diseaseSurgerymedicine.anatomical_structureCase-Control StudiesOrthopedic surgeryOsteoporosislcsh:RC925-935Radius FracturesbusinessResearch Article
researchProduct

[Osteoporosis and diabetes].

2011

Diabetes mellitus and osteoporosis are chronic diseases with an elevated and growing incidence in the elderly. Recent epidemiological studies have demonstrated an elevated risk of hip, humerus and foot fractures in elder diabetic subjects. While type 1 diabetes is generally associated with a mild reduction in bone mineral density (BMD), type 2 diabetes, more prevalent in old subjects, is frequently linked to a normal or high BMD. Studies on experimental models of diabetes have suggested an altered bone structure that may help to explain the elevated risk of fractures observed in these animals and may as well help to explain the paradox of an incremented risk of fractures in type 2 diabetic …

Malemedicine.medical_specialtylcsh:Internal medicineTime FactorsBone densityOsteoporosisPopulationlcsh:MedicineType 2 diabetesDiabetes Mellitus ExperimentalFractures BoneSex FactorsRheumatologyBone DensityRisk FactorsInternal medicineDiabetes mellitusHyperinsulinemiaMedicineAnimalsHumansHypoglycemic AgentsInsulinHypercalciuriaProspective Studieseducationlcsh:RC31-1245AgedAged 80 and overType 1 diabeteseducation.field_of_studybusiness.industrylcsh:RAge FactorsMiddle Agedmedicine.diseaseRatsEndocrinologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2OsteoporosisAccidental FallsFemalebusinessFollow-Up StudiesReumatismo
researchProduct

Exposed necrotic bone in 183 patients with bisphosphonate-related osteonecrosis of the jaw: Associated clinical characteristics

2017

The main objective of our study was to identify oral symptoms and signs most likely to be associated with the exposure of necrotic bone in bisphosphonate-related osteonecrosis of the jaw (BRONJ). The study group consisted of 183 patients with BRONJ. We recorded data on the underlying disease, bisphosphonate used, location of osteonecrosis, symptoms, pain, fistula development, suppuration, infection, exposed necrotic bone, and BRONJ stage. The mean age of the patients was 68.22 ± 12.19 years. The sample included 118 (64.5%) women. Breast cancer and multiple myeloma were the most common underlying diseases, and 50 patients received oral bisphosphonates for osteoporosis. Dental extractions (69…

Malemedicine.medical_specialtymedicine.medical_treatmentFistulaOsteoporosisOdontologíaMaxilares03 medical and health sciencesNecrosis0302 clinical medicineBreast cancermedicineHumansStage (cooking)General DentistryMultiple myelomaUNESCO:CIENCIAS MÉDICASAgedRetrospective StudiesOral Medicine and Pathologybusiness.industryResearchRetrospective cohort study030206 dentistryBisphosphonatemedicine.diseaseSurgeryOtorhinolaryngology030220 oncology & carcinogenesisBisphosphonate-Associated Osteonecrosis of the JawFemaleSurgerySymptom AssessmentOsteonecrosis of the jawbusiness
researchProduct

Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis

2016

OBJECTIVE: To describe the clinical characteristics and evolution of our series of medication-related osteonecrosis of the jaws (MRONJ) associated with denosumab in osteoporotic patients. MATERIAL AND METHODS: We present 10 new cases of MRONJ in patients receiving denosumab for osteoporosis. We describe the mean doses of denosumab, previous bisphosphonate intake, and the clinical characteristics associated with the osteonecrosis, such as local contributing factors, symptoms, and evolution after treatment. RESULTS: The mean number of denosumab doses was 3.4 2.2. In 90% of patients, there was a prior history of oral bisphosphonate intake, with a mean duration of 46.78 25.11 months. The most c…

Malemedicine.medical_specialtymedicine.medical_treatmentOsteoporosisDentistryOdontología03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansStage (cooking)General DentistryAgedSclerosisMedicamentoBisphosphonate-associated osteonecrosis of the jawBone Density Conservation AgentsDiphosphonatesbusiness.industry030206 dentistryMiddle AgedBisphosphonatemedicine.diseaseBone Density Conservation AgentsDenosumabOtorhinolaryngologyDental extraction030220 oncology & carcinogenesisOsteoporosisBisphosphonate-Associated Osteonecrosis of the JawFemaleDenosumabTomography X-Ray ComputedOsteonecrosis of the jawbusinessmedicine.drugOral Diseases
researchProduct

BRONJ in patients with rheumatoid arthritis: A multicenter case series

2016

Objective: Osteonecrosis of the jaw (ONJ) is a potentially severe adverse effect of various medications (bisphosphonates, anti-resorptive, and anti-angiogenic drugs). ONJ pathogenesis is still unclear although some risk factors have been recognized. Of these, rheumatoid arthritis (RA) has been hypothesized as a potential risk factor for developing ONJ. This observational study will describe a multicenter case series of patients affected with RA and ONJ, and it will attempt to evaluate the association between features of ONJ and pharmacological, systemic, and site variables. Methods: Demographic, pharmacological, and clinical data from 18 RA patients with ONJ were collected and registered fr…

Malemedicine.medical_specialtymedicine.medical_treatmentOsteoporosisONJArthritis Rheumatoid03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansBisphosphonateONJ; Bisphosphonate; Denosumab; Jaw; Osteonecrosis; Osteoporosis; Rheumatoid arthritis; Dentistry (all); Otorhinolaryngology2734 Pathology and Forensic MedicineRheumatoid arthritisAdverse effectGeneral DentistryRheumatoid arthritiAgedBisphosphonate-associated osteonecrosis of the jawbusiness.industryOtorhinolaryngology2734 Pathology and Forensic MedicineOsteoporosiOsteonecrosis030206 dentistryBisphosphonateMiddle Agedmedicine.diseaseSurgeryDenosumabOtorhinolaryngologyJaw030220 oncology & carcinogenesisRheumatoid arthritisOsteonecrosiDentistry (all)OsteoporosisMethotrexateBisphosphonate-Associated Osteonecrosis of the JawFemaleDenosumabbusinessOsteonecrosis of the jawmedicine.drug
researchProduct

Short-Term Precision Error of Bone Strain Index, a New DXA-Based Finite Element Analysis Software for Assessing Hip Strength

2020

Abstract Bone Strain Index (BSI) is a new finite element analysis tool applied to hip dual energy X-ray absorptiometry scans. The aim of this study was to assess the short-term precision error of BSI on the proximal femur, both on a phantom and patients. The International Society for Clinical Densitometry guidelines were followed for short-term precision error assessment. Dual energy X-ray absorptiometry measurements were performed on an anthropomorphic femur phantom that was scanned twice for 30 times, for a total of 60 scans. For the in vivo part, 30 subjects were scanned twice. BSI precision error was compared to that of bone mineral density (BMD). Both for the phantom and the in vivo st…

Malemusculoskeletal diseases0301 basic medicineEndocrinology Diabetes and MetabolismCoefficient of variationFinite Element Analysis030209 endocrinology & metabolismPatient PositioningImaging phantom03 medical and health sciencesAbsorptiometry Photon0302 clinical medicineBone DensitymedicineHumansRadiology Nuclear Medicine and imagingOrthopedics and Sports MedicineFemurFemurDual-energy X-ray absorptiometryAgedFemoral neckBone mineralReproducibilitymedicine.diagnostic_testPhantoms Imagingbusiness.industryReproducibility of Resultsbacterial infections and mycosesmedicine.anatomical_structureOsteoporosisFemale030101 anatomy & morphologyDensitometrybusinessNuclear medicinehuman activitiesSoftwareJournal of Clinical Densitometry
researchProduct

Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey

2007

Introduction Few data are available about the incidence and costs of hip fractures in Italy. We aimed to determine the impact of hip fractures vs. acute myocardial infarction (AMI). Methods We studied the national hospitalization database to calculate their incidence and costs in adults aged ≥45 between 1999 and 2002. Results In 2002, there were 86,719 hip fractures with a 10.0% increase over 4 years. We observed a predominance of women (77.1%) and a strong age effect: 92.7% of patients were ≥65 years old and 80% of fractures occurred in women aged ≥75, showing a clear relationship with the incidence of osteoporosis. Hospitalizations due to AMI after 45 years of age in 1999 were only 9% hig…

Malemusculoskeletal diseasesAgingmedicine.medical_specialtyHeart diseaseCostEpidemiologyEndocrinology Diabetes and MetabolismOsteoporosisacute myocardial infarctionPoison controlhip fractures; myocardial infarctionAMIAge Distributionhip fracture myocardial infarction italian populationInjury preventionEpidemiologyHumansMedicinecardiovascular diseasesMyocardial infarctionSex Distributionhealth care economics and organizationsAgedbusiness.industryIncidenceIncidence (epidemiology)Health Care CostsLength of StayMiddle Agedmedicine.diseaseHospitalizationmyocardial infarctionItalyhip fractureHealth Care Surveyship fracturesEmergency medicineOrthopedic surgeryPhysical therapyFemaleitalian populationbusiness
researchProduct

Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate

2005

Abstract Objective: Androgen-deprivation therapy (ADT) is the usual treatment for locally advanced or metastatic prostate cancer. Osteoporosis is a common complication of ADT. The aim of our study was to evaluate the efficacy of neridronate, a relatively new bisphosphonate to prevent bone loss during androgen ablation. Methods: Sixty patients with prostate cancer and osteoporosis were enrolled and randomly assigned to 2 different treatment regimes: group A (30 patients) treated with maximum androgenic blockage (MAB), and group B (30 patients) treated with bicalutamide 150mg. Each group was divided in 2 subgroups A1–A2 and B1–B2. All patients received calcium and cholecalciferol supplements …

Malemusculoskeletal diseasesmedicine.medical_specialtyDeoxypyridinolineBone densityBicalutamideUrologymedicine.medical_treatmentOsteoporosisUrologyImmunoenzyme TechniquesTosyl CompoundsAndrogen deprivation therapyProstate cancerchemistry.chemical_compoundAbsorptiometry PhotonBone DensityNitrilesmedicineHumansNeridronic acidAnilidesTestosteroneAmino AcidsVitamin DChromatography High Pressure LiquidAgedAged 80 and overDiphosphonatesEstradiolbusiness.industryProstatic NeoplasmsAndrogen AntagonistsPhosphorusBisphosphonatemedicine.diseaseSurgeryTreatment OutcomechemistryParathyroid HormoneOsteoporosisCalciumDrug Therapy CombinationbusinessBiomarkersFollow-Up Studiesmedicine.drug
researchProduct

Hip fractures and femoral bone mineral density in male former elite athletes

2009

We studied whether vigorous physical activity in young adulthood is associated with higher femoral bone density and lower risk of hip fracture at older age in men.A cohort of former male elite athletes (n=2147) and matched control subjects (n=1467) were studied for their leisure physical activity, and for fragility fractures at the hip (proximal femur) by Cox regression. Areal bone mineral densities (aBMD) at femoral neck and trochanter region were measured using dual-energy X-ray absorptiometry in a subgroup of the former athletes (n=87; median age 59 years) and in a population-based control group (n=194) and compared by general linear models.After their active sporting careers, the former…

Malemusculoskeletal diseasesmedicine.medical_specialtyHistologyPhysiologyEndocrinology Diabetes and MetabolismPopulationOsteoporosis030209 endocrinology & metabolismBody Mass Index03 medical and health sciences0302 clinical medicineBone DensityRisk FactorsSurveys and QuestionnairesHumansMedicineFemurFemur030212 general & internal medicine10. No inequalityeducationFemoral neckeducation.field_of_studyHip fractureTrochanterbiologyFemur NeckHip Fracturesbusiness.industryAthletesMiddle Agedbiology.organism_classificationmedicine.diseaseSurgerymedicine.anatomical_structureAthletesCase-Control StudiesHip bonePhysical therapybusinessBone
researchProduct